ArticleMolecular cancer therapeutics2014

Efficacy of RG7787, a next-generation mesothelin-targeted immunotoxin, against triple-negative breast and gastric cancers.

Christine Alewine et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.